ADA CUC 2025 Resource Hub  – 

Welcome to our resource hub for ADA Clinical Update Course 2025! This is a one-stop-shop for everything on the conference. We will be updating the resource hub daily, so check back in for the latest on this magical meeting.

Day-of Conference Reports

Conference Highlights 

  1. Time in euglycemia: Medtronic’s Dr. Robert Vigersky proposes 50-55% TITR as most appropriate target to reduce risk of complications
  2. Key updates in the 2025 ADA Standards of Care: CGM for non-insulin T2D, tech use in the hospital and pregnancy, compounded GLP-1 RAs, and more!
  3. Dr. Stephen Brunton celebrates the “evolution” and “revolution” of diabetes management over decades in opening keynote
  4. “We cannot leave nutrition behind”: Dr. Victoria Bouhairie shares strategies to incorporate healthy eating habits into patient care
  5. Exploring T1D vs T2D, considering patient goals, and, essentially, exercise: a lively case study discussion
  6. Midlife, Menopause, and Diabetes in whole women health: The importance of understanding menopause, exercise, and potential hormone replacement therapy
  7. Addressing increasing issue of men’s health in diabetes
  8. A first glimpse at the Exhibit Hall
  9. Hyperglycemic crises: Dr. Rodolfo Galindo reviews the 2024 consensus statement and offers structural approach to DKA management
  10. Dr. Rozalina McCoy shares diabetes classification strategies for T1D, T2D, and LADA
  11. Preserving muscle mass: The importance of pairing exercise and sufficient protein intake with GLP-1 RA therapies
  12. Dr. Sylvia Rosas explores CKD prevention and treatment, from pharmacotherapy to real-world considerations
  13. Dr. Samar Hafida shares practical, clinical considerations for obesity pharmacotherapy
  14. Dr. Sagar Dugani on the present and future of diabetes care in underserved populations
  15. It takes a village: Dr. Kimberly Gudzune on team-based, methodical approaches to obesity and mental health issues
  16. Dr. Elizabeth Beverly reviews psychosocial care for people with diabetes in the 2025 ADA SOC
  17. “Wild, Wild West”: Dr. Joshua Neumiller advises against compounded products
  18. Dr. John Anderson spotlights present and future CV risk management strategies, including in asymptomatic individuals
  19. GLP-1 RAs beyond obesity: Dr. Joshua Neumiller reviews expanding indications of incretin-based therapies
  20. Dr. Grazia Aleppo on the latest in diabetes technology: CGM coverage for T2D not on insulin, OTC CGM, and AID for T2D
  21. “Purely scientific solutions to societal problems are doomed to fail”: Dr. David Kerr on AI in diabetes and primary care

Previous ADA Clinical Update Course (Formerly ADA Postgrad) Coverage on CCKB

ADA CUC 2025 Resource Hub -
Top